322 related articles for article (PubMed ID: 15947487)
1. Effects of corticosteroid on the expression of thymus and activation-regulated chemokine in a murine model of allergic asthma.
Kurokawa M; Kokubu F; Matsukura S; Kawaguchi M; Ieki K; Suzuki S; Odaka M; Watanabe S; Takeuchi H; Akabane T; Asano K; Iwase M; Honma I; Adachi M
Int Arch Allergy Immunol; 2005; 137 Suppl 1():60-8. PubMed ID: 15947487
[TBL] [Abstract][Full Text] [Related]
2. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions.
Bochner BS; Hudson SA; Xiao HQ; Liu MC
J Allergy Clin Immunol; 2003 Nov; 112(5):930-4. PubMed ID: 14610482
[TBL] [Abstract][Full Text] [Related]
3. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice.
Kawasaki S; Takizawa H; Yoneyama H; Nakayama T; Fujisawa R; Izumizaki M; Imai T; Yoshie O; Homma I; Yamamoto K; Matsushima K
J Immunol; 2001 Feb; 166(3):2055-62. PubMed ID: 11160256
[TBL] [Abstract][Full Text] [Related]
4. Histamine type 1 receptor deficiency reduces airway inflammation in a murine asthma model.
Miyamoto K; Iwase M; Nyui M; Arata S; Sakai Y; Gabazza EC; Kimura H; Homma I
Int Arch Allergy Immunol; 2006; 140(3):215-22. PubMed ID: 16685135
[TBL] [Abstract][Full Text] [Related]
5. Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts.
Berin MC; Eckmann L; Broide DH; Kagnoff MF
Am J Respir Cell Mol Biol; 2001 Apr; 24(4):382-9. PubMed ID: 11306430
[TBL] [Abstract][Full Text] [Related]
6. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensis.
KuoLee R; Zhou H; Harris G; Zhao X; Qiu H; Patel GB; Chen W
Clin Exp Allergy; 2008 Jun; 38(6):1003-15. PubMed ID: 18307525
[TBL] [Abstract][Full Text] [Related]
8. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
[TBL] [Abstract][Full Text] [Related]
9. Effects of furosemide on allergic asthmatic responses in mice.
Wang S; Xiang YY; Ellis R; Wattie J; Feng M; Inman MD; Lu WY
Clin Exp Allergy; 2011 Oct; 41(10):1456-67. PubMed ID: 21729180
[TBL] [Abstract][Full Text] [Related]
10. CTLA4-IgG reverses asthma manifestations in a mild but not in a more "severe" ongoing murine model.
Deurloo DT; van Esch BC; Hofstra CL; Nijkamp FP; van Oosterhout AJ
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):751-60. PubMed ID: 11726402
[TBL] [Abstract][Full Text] [Related]
11. α-Galactosylceramide-induced airway eosinophilia is mediated through the activation of NKT cells.
Chuang YH; Wang TC; Jen HY; Yu AL; Chiang BL
J Immunol; 2011 Apr; 186(8):4687-92. PubMed ID: 21383248
[TBL] [Abstract][Full Text] [Related]
12. Characteristic features of allergic airway inflammation in a murine model of infantile asthma.
Ohki Y; Tokuyama K; Mayuzumi H; Sato A; Koyama H; Takizawa T; Arakawa H; Mochizuki H; Morikawa A
Int Arch Allergy Immunol; 2005 Sep; 138(1):51-8. PubMed ID: 16103687
[TBL] [Abstract][Full Text] [Related]
13. Female mice are more susceptible to the development of allergic airway inflammation than male mice.
Melgert BN; Postma DS; Kuipers I; Geerlings M; Luinge MA; van der Strate BW; Kerstjens HA; Timens W; Hylkema MN
Clin Exp Allergy; 2005 Nov; 35(11):1496-503. PubMed ID: 16297148
[TBL] [Abstract][Full Text] [Related]
14. Targeted reduction of CCR4⁺ cells is sufficient to suppress allergic airway inflammation.
Honjo A; Ogawa H; Azuma M; Tezuka T; Sone S; Biragyn A; Nishioka Y
Respir Investig; 2013 Dec; 51(4):241-9. PubMed ID: 24238232
[TBL] [Abstract][Full Text] [Related]
15. Allergen-specific polyclonal antibodies reduce allergic disease in a mouse model of allergic asthma.
Moerch U; Haahr Hansen M; Vest Hansen NJ; Rasmussen LK; Oleksiewicz MB; Frandsen TP; Haurum JS; Bregenholt S
Int Arch Allergy Immunol; 2006; 140(3):261-9. PubMed ID: 16699287
[TBL] [Abstract][Full Text] [Related]
16. Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice.
Vestergaard C; Deleuran M; Gesser B; Larsen CG
Exp Dermatol; 2004 Apr; 13(4):265-71. PubMed ID: 15086343
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model.
Lee KS; Lee HK; Hayflick JS; Lee YC; Puri KD
FASEB J; 2006 Mar; 20(3):455-65. PubMed ID: 16507763
[TBL] [Abstract][Full Text] [Related]
18. Expression of interleukin-17F in a mouse model of allergic asthma.
Suzuki S; Kokubu F; Kawaguchi M; Homma T; Odaka M; Watanabe S; Ieki K; Matsukura S; Kurokawa M; Takeuchi H; Sasaki Y; Huang SK; Adachi M; Ota H
Int Arch Allergy Immunol; 2007; 143 Suppl 1():89-94. PubMed ID: 17541285
[TBL] [Abstract][Full Text] [Related]
19. Induction of a late asthmatic response associated with airway inflammation in mice.
Nabe T; Zindl CL; Jung YW; Stephens R; Sakamoto A; Kohno S; Atkinson TP; Chaplin DD
Eur J Pharmacol; 2005 Oct; 521(1-3):144-55. PubMed ID: 16182277
[TBL] [Abstract][Full Text] [Related]
20. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice.
Yoneyama H; Harada A; Imai T; Baba M; Yoshie O; Zhang Y; Higashi H; Murai M; Asakura H; Matsushima K
J Clin Invest; 1998 Dec; 102(11):1933-41. PubMed ID: 9835618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
